When the Food and Drug Administration announced that the agency would be removing the black-box warning from hormone ...
An estrogen-like drug, raloxifene, has no demonstrated benefit on memory and thinking skills for women with dementia due to Alzheimer's disease, according to a study published in the November 4, 2015, ...
The U.S. Food and Drug Administration (FDA) announced this week that it would no longer require "black box warnings"-the highest level of medication safety warnings-on prescription low-dose estrogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results